The shareholders of Biomed Lublin decided not to pay the dividend for 2021.Warsaw, 01/07/2022 (ISBnews) – During the general meeting, the shareholders of Biomed Lublin decided not to pay dividends and allocate the entire profit for 2021, in the amount of PLN 4.25 million, to cover losses from previous years, the company said.

“Ordinary general meeting of the company. Net profit for the period from January 1, 2021 to December 31, 2021 in the amount of: PLN 4,249 thousand. decides to allocate to cover losses from previous years, ”reads the resolution of the general meeting.

Biomed-Lublin Wytwórnia Surowic i Szczepionek is a Polish pharmaceutical company operating since 1944. The company produces medicinal preparations (prescription drugs, medical devices and laboratory reagents used in biochemical and medical laboratories). The company has been listed on the main market of the WSE since 2015.

(ISBnews)




Follow us on Google News. Search for what’s important and stay up to date with the market! Watch us >>